| Metric | FY 2025↕ | FY 2021↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ | FY 2016↕ | FY 2015↕ | FY 2014↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.0B | $8.5B | $7.6B | $1.9B | $1.9B | $1.8B | $1.8B | $11.5B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $2.1B | $1.7B | $2.8B | $0.7B | $0.8B | $0.7B | $0.6B | $1.0B |
| Net Income | $1.2B | $0.9B | $1.5B | $0.4B | $0.1B | $0.5B | $0.4B | $0.7B |
| EPS (Basic) | $1.60 | $1.20 | $1.91 | $0.57 | $0.11 | $0.68 | $0.59 | $1.04 |
| EPS (Diluted) | $1.59 | $1.20 | $1.91 | $0.57 | $0.11 | $0.68 | $0.59 | $1.04 |
| Metric | FY 2025↕ | FY 2021↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ | FY 2016↕ | FY 2015↕ | FY 2014↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $45.2B | $41.1B | $48.1B | $43.4B | $41.5B | $38.3B | $39.3B | $48.9B |
| Current Assets | $3.9B | $2.9B | $2.8B | $2.4B | $2.3B | $2.1B | $2.6B | $6.2B |
| Cash & Equivalents | $1.1B | $0.3B | $0.7B | $0.6B | $0.5B | $0.3B | $0.8B | $1.8B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $4.5B | $3.3B | $6.0B | $4.6B | $4.0B | $3.8B | $3.9B | $7.4B |
| Stockholders' Equity | — | $13.9B | $13.4B | $11.7B | $10.8B | $9.9B | $9.9B | $13.6B |
| Metric | FY 2025↕ | FY 2021↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ | FY 2016↕ | FY 2015↕ | FY 2014↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.6B | $2.3B | $2.7B | $2.8B | $2.5B | $2.9B | $2.6B | $3.4B |
| Investing Cash Flow | $-4.0B | $-2.8B | $-3.3B | $-3.4B | $-3.2B | $-2.9B | $-3.6B | $-3.3B |
| Capital Expenditures | $4.0B | $2.8B | $3.2B | $3.2B | $3.1B | $2.9B | $3.5B | $4.1B |
| Financing Cash Flow | $2.1B | $0.4B | $0.4B | $0.7B | $0.8B | $-0.4B | $0.1B | $0.6B |